Erik Laursen
Consulente / Consigliere presso Propel Bio Partners LLC
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Richard Kayne | M | 79 |
Propel Bio Partners LLC
 Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
| Leen Kawas | M | 38 |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
| Carol Criner | F | - |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
| Sylvia Mcbrinn | F | 71 |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
| Ronald Lee Krall | M | - |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
| Richard Sudek | M | - |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
| Xue Hua | M | - |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
| Suzanne Hendrix | M | - |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | - |
| Ron Farkas | M | - |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | - |
| Mike Gibbs | M | - |
Propel Bio Partners LLC
Propel Bio Partners LLC Investment ManagersFinance Propel Bio Partners LLC (Propel Bio Partners) is a venture capital firm founded in 2022 by Leen Kawas and Richard Alan Kayne. The firm is headquartered in Los Angeles, California. | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| James R. Piggott | M | 69 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 9 anni |
| Lars Secher Knudsen | M | - |
Technical University of Denmark
| 1 anni |
| Sven Erik Oppelstrup Madsen | M | 70 |
Technical University of Denmark
| 4 anni |
| John Ødegaard | M | - |
Technical University of Denmark
| 1 anni |
| Peter Boman Samuelsen | M | - |
Technical University of Denmark
| 2 anni |
| Niels Borum | M | 76 |
Technical University of Denmark
| 1 anni |
| Mogens Munkholm Elsberg | M | 69 |
Technical University of Denmark
| 5 anni |
| Niels Lykke Graugaard | M | 77 |
Technical University of Denmark
| 4 anni |
| Søren Anker Rasmussen | M | 75 |
Technical University of Denmark
| 1 anni |
| Lars Christian Pallesen | M | 76 |
Technical University of Denmark
| 4 anni |
| Kurt Ottesen | M | - |
Technical University of Denmark
| 1 anni |
| Gregory D. Phelps | M | 75 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 2 anni |
| Ole Lüthcke Christensen | M | - |
Technical University of Denmark
| 1 anni |
| Martin Edwards | M | 68 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 3 anni |
| Tom Kähler | M | 81 |
Technical University of Denmark
| 1 anni |
| Niels Bergh-Hansen | M | 76 |
Technical University of Denmark
| 1 anni |
| Torkil Bentzen | M | 78 |
Technical University of Denmark
| 4 anni |
| Mads Laustsen | M | 67 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 8 anni |
| Jørn Webler | M | 73 |
Technical University of Denmark
| 1 anni |
| Jørgen Lindegaard | M | 76 |
Technical University of Denmark
| 1 anni |
| Lars Rebien Sørensen | M | 69 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 14 anni |
| Søren Kähler | M | 73 |
Technical University of Denmark
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Danimarca | 17 | 53.13% |
| Stati Uniti | 15 | 46.88% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Erik Laursen
- Contatti personali
